See also this year's filing and all EDGAR filings for this company.
PDF Report 0001488613_2018_Foundation_Medicine_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 152903000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.3730487890242195, 'aggregate_val': 313846000, 'exp_sum': 228576000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 70340000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 66727000, 'ResearchAndDevelopmentExpense': 91509000, 'remainder_Expenses': 0}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001488613, Foundation Medicine Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 1,760,000 |
| 2 | AssetsCurrent | 123,819,000 |
| 3 | PropertyPlantAndEquipment | 41,119,000 |
| 4 | remainder_Assets | 2,305,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 66,443,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 70,340,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 66,727,000 |
| 15 | ResearchAndDevelopmentExpense | 91,509,000 |
| 16 | remainder_Expenses | 85,270,000 |
| 17 | remainder_Revenues | 152,903,000 |
| 18 | remainder_NetIncome | -523,000 |
| 19 | remainder_ComprehensiveNetIncome | 123,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 169,003,000 |
| 1 | Liabilities | 66,443,000 |
| 2 | Expenses | 313,846,000 |
| 3 | Revenues | 152,903,000 |
| 4 | StockholdersEquity | 102,560,000 |
| 5 | NetIncome | -161,466,000 |
| 6 | ComprehensiveNetIncome | -161,343,000 |
| 7 | BaseVar | 351,420,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.107 |
| 9 | EconomicCapitalRatio | 0.872 |